CARRIERI, Antonio
 Distribuzione geografica
Continente #
NA - Nord America 5.197
EU - Europa 1.965
AS - Asia 893
SA - Sud America 10
AF - Africa 9
OC - Oceania 5
Totale 8.079
Nazione #
US - Stati Uniti d'America 5.180
CN - Cina 498
DE - Germania 443
SE - Svezia 396
IT - Italia 326
SG - Singapore 207
UA - Ucraina 159
GB - Regno Unito 149
RU - Federazione Russa 138
FR - Francia 128
FI - Finlandia 105
VN - Vietnam 92
IE - Irlanda 33
IN - India 33
BE - Belgio 24
CH - Svizzera 16
NL - Olanda 15
IR - Iran 14
HK - Hong Kong 11
CA - Canada 10
TR - Turchia 9
BR - Brasile 8
CZ - Repubblica Ceca 8
JP - Giappone 6
LT - Lituania 6
ES - Italia 5
PL - Polonia 5
AU - Australia 4
JM - Giamaica 4
KR - Corea 4
NG - Nigeria 4
TH - Thailandia 4
EG - Egitto 3
ID - Indonesia 3
CL - Cile 2
DK - Danimarca 2
DZ - Algeria 2
IQ - Iraq 2
MX - Messico 2
MY - Malesia 2
TW - Taiwan 2
AN - Antille olandesi 1
GE - Georgia 1
HR - Croazia 1
IS - Islanda 1
KZ - Kazakistan 1
LB - Libano 1
LI - Liechtenstein 1
MN - Mongolia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PT - Portogallo 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
Totale 8.079
Città #
Fairfield 725
Woodbridge 506
Chandler 505
Houston 386
Jacksonville 354
Ashburn 331
Nyköping 298
Seattle 279
Cambridge 251
Wilmington 237
Ann Arbor 222
Singapore 170
Bari 122
Nanjing 113
Lawrence 107
Roxbury 107
Marseille 97
Dong Ket 84
Boardman 70
Beijing 65
Des Moines 64
Princeton 58
New York 52
Brooklyn 41
San Diego 39
Jiaxing 32
Dublin 31
Inglewood 31
Munich 29
Nanchang 29
Los Angeles 27
London 25
Brussels 24
Milan 23
Santa Clara 23
Shenyang 22
Redwood City 18
Tianjin 18
Dearborn 16
West Jordan 16
Changsha 15
Hebei 15
Guangzhou 14
Helsinki 14
Paris 13
Kansas City 12
Leawood 11
Shanghai 11
Amsterdam 10
Boydton 9
Falls Church 9
Mumbai 9
Wuhan 9
Brno 8
Long Beach 8
Grafing 7
Hanoi 7
Jinhua 7
Lausanne 7
San Mateo 7
Santa Marinella 7
Toronto 7
Triggiano 7
Zhengzhou 7
Hefei 6
Pune 6
Sannicandro di Bari 6
St Albans 6
Turin 6
Auburn Hills 5
Bitonto 5
Brindisi 5
Frankfurt am Main 5
Istanbul 5
Norwalk 5
Nuremberg 5
Rome 5
Ardabil 4
Augusta 4
Cedar Knolls 4
Delhi 4
Guys Hill 4
Kunming 4
Lagos 4
Messina 4
Monmouth Junction 4
Romola 4
Shenzhen 4
St Petersburg 4
Taizhou 4
Washington 4
Wuxi 4
Bhubaneswar 3
Bologna 3
Cairo 3
Camerino 3
Chengdu 3
Düsseldorf 3
Florence 3
Haikou 3
Totale 6.031
Nome #
1, 3‐Benzothiazoles as Antimicrobial Agents 251
1,3-Benzothiazoles as Antimicrobial Agents 238
1,2,3,4-Tetrahydroisoquinoline/2H-chromen-2-one conjugates as nanomolar P-glycoprotein inhibitors: Molecular determinants for affinity and selectivity over multidrug resistance associated protein 1 227
miRNAs for the Detection of MultiDrug Resistance: Overview and Perspectives 153
Chasing ChEs-MAO B Multi-Targeting 4-Aminomethyl-7-Benzyloxy-2H-Chromen-2-ones 142
4H-1,4-benzothiazine, dihydro-1,4-benzothiazinones and 2-amino-5- fluorobenzenethiol derivatives: Design, synthesis and in vitro antimicrobial screening 136
2-Aminobenzothiazole derivatives: Search for new antifungal agents 125
Involvement of I2-imidazoline binding sites in positive and negative morphine analgesia modulatory effects 122
Synthesis, in vitro evaluation, and molecular modeling investigation of benzenesulfonimide peroxisome proliferator-activated receptors α antagonists 122
A convenient synthesis of lubeluzole and its enantiomer: Evaluation as chemosensitizing agents on human ovarian adenocarcinoma and lung carcinoma cells 120
Structure-property relationship study of the HPLC enantio-selective retention of neuroprotective 7-[(1-alkylpiperidin-3-yl)methoxy]coumarin derivatives on an amylose-based chiral stationary phase 117
Probiotic and Tea Tree Oil Treatments Improve Therapy of Vaginal Candidiasis: A Preliminary Clinical Study 116
The chemosensitizing agent lubeluzole binds calmodulin and inhibits Ca2+/calmodulin-dependent Kinase II 109
Investigating 1,2,3,4,5,6-hexahydroazepino[4,3-b]indole as scaffold of butyrylcholinesterase-selective inhibitors with additional neuroprotective activities for Alzheimer's disease 109
High Affinity Central Benzodiazepine Receptor Ligands. Part 2: Quantitative Structure-Activity Relationships and Comparative Molecular Field Analysis of Pyrazolo[4,3-c]quinolin-3-ones 106
Lipophilicity of teicoplanin antibiotics as assessed by reversed phase high-performance liquid chromatography: quantitative structure-property and structure-activity relationships 104
Repositioning of Endonuclear Receptors Binders as Potential Antibacterial and Antifungal Agents. Eptyloxìm: A Potential and Novel Gyrase B and Cytochrome Cyp51 Inhibitor 100
In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp 100
,3-Benzothiazoles as Antimicrobial Agents 98
2-(2-Phenylcyclopropyl)-Imidazolines: Reversed Enantioselective Interaction At I1 and I2 Imidazoline Receptors 98
Ligands of neuronal nicotinic acetylcholine receptor (nAChR): inferences from the Hansch and 3-D Quantitative Structure-Activity Relationship (QSAR) models 97
New tetrahydroisoquinoline-based P-glycoprotein modulators: Decoration of the biphenyl core gives selective ligands 96
Structure-Activity Relationship Studies on Tetrahydroisoquinoline Derivatives: [4′-(6,7-Dimethoxy-3,4-dihydro-1H-isoquinolin-2-ylmethyl)biphenyl-4-ol] (MC70) Conjugated through Flexible Alkyl Chains with Furazan Moieties Gives Rise to Potent and Selective Ligands of P-glycoprotein 94
Synthesis.and biological evaluation of pyridazino[4,3-b]indoles and indeno[1,2-c]pyridazines as new ligands of central and peripheral benzodiazepine receptors 93
MOLECULAR DETERMINANTS FOR NUCLEAR RECEPTORS SELECTIVITY: CHEMOMETRIC ANALYSIS, DOCKINGS AND SITE-DIRECTED MUTAGENESIS OF DUAL PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS α/γ AGONISTS 92
Investigation on platelet aggregation inhibitory activity by phenyl amides and esters of piperidinecarboxylic acids 91
Elucidation of the synergistic action of Mentha Piperita essential oil with common antimicrobials 89
Coumarin, chromone, and 4(3H)-pyrimidinone novel bicyclic and tricyclic derivatives as antiplatelet agents: synthesis, biological evaluation, and comparative molecular field analysis 88
Structural Determinants in the Binding of BB2 Receptor Ligands: In Silico, X-Ray and NMR Studies in PD176252 Analogues. 88
The Versatile 2-Substituted Imidazoline Nucleus as a Structural Motif of Ligands Directed to the Serotonin 5-HT1A Receptor 85
Understanding of the MAO-A and B Reversible Inhibitory Activity and Selectivity by Using 3D Descriptors of Lipophilicity 84
Effect of Methyl -β- Cyclodextrin on the antimicrobial activity of a new series of poorly water-soluble benzothiazoles 84
Beyond the Canonical Endocannabinoid System. A Screening of PPAR Ligands as FAAH Inhibitors 83
Binding Models of Reversible Inhibitors to Monoamine Oxidases 81
The in silico insights of α-adrenergic receptors over the last decade: methodological approaches and structural features of the 3D models 81
Guinea-pig ileum as ex vivo model useful to characterize ligands displaying Imidazoline I2 and Adrenergic alpha2 mixed activity: a preliminary study 80
Papain catalyzed hydrolysis of aryl esters: a comparison of the Hansch, Docking and CoMFA methods 78
High affinity central benzodiazepine receptor ligands: synthesis and structure-activity relationship studies of a new series of pyrazolo[4,3-c]quinolin-3-ones. 77
3D-QSAR models and docking studies of reversible inhibitors of type A and B Monoamine Oxidases 76
Neuronal Nicotinic Agonists: a Multi-approach Development of the Pharmacophore 76
Ligand binding to I2 imidazoline receptor: the role of lipophilicity in quantitative structure-activity relationship models. 75
Enhanced solubility and antibacterial activity of lipophilic fluoro-substituted N-benzoyl-2-aminobenzothiazoles by complexation with beta-cyclodextrins 75
Natural and synthetic geiparvarins are strong and selective MAO-B inhibitors. Synthesis and SAR studies. 74
Lubeluzole: from anti-ischemic to chemosensitizing agent 74
Might the observed a2A-adrenoreceptor agonism or antagonism of allyphenyline analogues be ascribed to different molecular conformations? 73
High affinity central benzodiazepine receptor ligands II: QSAR studies and CoMFA analysis pyrazolo(4,3-c)quinolin-3-ones 72
Neuronal nicotinic receptor agonists: multi-approach pharmacophore development and 3D-QSAR predictive models, 70
null 70
Dioxane and oxathiane nuclei: suitable substructures for muscarinic agonists 69
Design, synthesis and biological evaluation of a class of bioisosteric oximes of the novel dual peroxisome proliferator-activated receptor alpha/gamma ligand LT175 68
Conformationally constrained butyrophenones with mixed dopaminergic (D(2)) and serotoninergic (5-HT(2A), 5-HT(2C)) affinities: synthesis, pharmacology, 3D-QSAR, and molecular modeling of (aminoalkyl)benzo- and -thienocycloalkanones as putative atypical antipsychotics. 67
null 66
Derivatives of Tenuazonic Acid as Potential New Multi-Target Anti-Alzheimer’s Disease Agents 66
null 65
Alpidem analogues containinig a GABA or glycine moiety as new anticonvulsant agents 62
Diffuse Intrinsic Pontine Glioma (DIPG): breakthrough and clinical perspective 62
Evaluation of water‐soluble Mannich base prodrugs of 2,3,4,5‐tetrahydroazepino[4,3‐b]indol‐1(6H)‐one as multitarget‐directed agents for Alzheimer’s disease 62
Binding models of reversible inhibitors to type-B monoamine oxidase 61
Rational design of the new antihypertensive I1-receptor ligand 2-(2-biphenyl-2-yl-1-methyl-ethyl-)4,5-dihydro-1H-imidazole 60
Allyphenyline Analogues Potentially Useful in the Management of Chronic Pain and Opioid Addiction 59
Pharmacophore development and 3D-QSAR study of I1 imidazoline binding site ligands 58
Molecular determinants for nuclear receptors selectivity: chemometric analysis, dockings and site-directed mutagenesis of dual peroxisome proliferator-activated receptors alpha/gamma agonists 58
null 57
Alpha2-adrenoreceptors profile modulation. 3.1 (R)-(+)-m-nitrobiphenyline, a new efficient and alpha2C-subtype selective agonist 56
null 56
1,3,5-triazine derivatives as dual inhibitors of 5-HT6R/FAAH in search of new therapy for Alzheimer's disease 55
Recent Trends And Future Prospects In Computational GPCR Drug Discovery: From Virtual Screening To Polypharmacology. 55
Comparative Molecular Field Analysis of pyridawinone-containing alfa1-antagonists 54
Linezolid hybrid analogs: synthesis and antimicrobial studies of oxalodinone-mercaptobenzothiazole compounds 53
Dimeric analogs of the dual PPARα/γ agonist LT-175: design, synthesis and biological evaluation. 53
Bioisosteric Modification of To042: Synthesis and Evaluation of Promising Use-Dependent Inhibitors of Voltage-Gated Sodium Channels 53
SAR of Non-Nucleoside HIV-1 RT inhibitors (NNRTIs): Comparative Molecular field Analysis (CoMFA) and Docking Studies 52
Neuronal nicotinic receptor agonists: multi-approach pharmacophore development and 3D QSAR predictive models 52
Multi-approach development of a new pharmacophore for neuronal nicotinic acetylcholine receptor agonists, 51
alfa2-adrenoreceptors profile modulation. 2.1 Biphenyline analogues as tools for selective activation of alfa2C-subtype 49
Binding of tracizolines to the imidazoline receptor: the role of lipophilicity in quantitative structure-activity relationship models 49
alpha2-adrenoreceptors profile modulation and high antinociceptive activity of (S)-(-)-2-[1-(Biphenyl-2-yloxy)ethyl]-4,5-dihydro-1H-imidazole 49
(contributo in convegno) MOLECULAR DETERMINANTS FOR NUCLEAR RECEPTORS SELECTIVITY; CHEMOMETRIC ANALYSIS, DOCKINGS AND SITE-DIRECTED MUTAGENESIS OF DUAL PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS α/γ AGONISTS 49
Scouting around 1,2,3,4-Tetrahydrochromeno[3,2-c]pyridin-10-ones for Single- and Multitarget Ligands Directed towards Relevant Alzheimer's Targets 49
Modeling the structural basis of the human CCR5 chemokine receptor functions: from homology model-builiding and molecular dynamics validation to agonist and anatgonist docking 48
2-D and 3-D modeling of imadazoline receptor ligands: insights into pharmacophore 48
Analisi conduttimetrica 46
Sintesi alternativa del lubeluzolo e del suo enantiomero e valutazione come agenti in grado di potenziare l'effetto di farmaci antitumorali. 45
stant collaboration in drug discovery: The LINK3D project 45
Synthesis and Antimicrobial Activity of new-substitud-4H-1,4-benzothiazines 44
New molecular requirements of Toc derivatives bearing a novel class of Nav1.4 blockers 42
null 42
Progettazione e sintesi di nuovi agenti antimicrobici e studio dell'attività biologica in associazione con differenti olii essenziali 39
Extended form of a retro-inverso peptide stabilized by beta-sheet unidirectional H-bonds: Crystallographic and NMR evidence 39
Structure-based design of novel donepezil-like hybrids for a multi-target approach to the therapy of Alzheimer's disease 39
DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF NEW ANALOGS OF THE DUAL PPARα/γ AGONIST LT175. 38
null 38
A New Series of Aryloxyacetic Acids Endowed with Multi-Target Activity towards Peroxisome Proliferator-Activated Receptors (PPARs), Fatty Acid Amide Hydrolase (FAAH), and Acetylcholinesterase (AChE) 38
Theoretical evidence of a salt bridge disruption as the initiating process for the alpha1d-adrenergic receptor activation: a molecular dynamics and docking study 37
Distant collaboration in drug discovery: The LINK3D project 34
Design, synthesis and biological evaluation of a dimeric analog of the dual PPARα/γ agonist 2-(4-phenyl-phenoxy)-3-phenyl-propanoic acid. 33
Non-Antibiotic Drug Repositioning as an Alternative Antimicrobial Approach 32
null 31
Determinanti Molecolari della Selettività di Recettori Nucleari: Analisi Chemiometrica e Docking di Agonisti Selettivi di Recettori PPARs 31
null 30
Totale 7.583
Categoria #
all - tutte 36.641
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.641


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020803 0 0 0 0 0 0 178 146 225 78 140 36
2020/20211.324 175 72 90 94 110 61 103 70 111 180 105 153
2021/2022851 43 105 11 41 22 48 49 44 56 84 134 214
2022/20231.556 220 141 93 125 183 190 14 155 337 22 40 36
2023/2024675 44 99 26 43 52 102 40 29 39 54 52 95
2024/2025697 73 69 196 109 66 165 19 0 0 0 0 0
Totale 8.432